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Medication adherence
has been a long standing and daunting
issue for both patients with mental
health disorders and health care
providers. According to (Brown & Gray,
2015) there is much need to address
the problem of medication adherence
in patients with mental illnesses and
the role of health care providers. This
issue calls for a thorough evaluation of
how psychiatric medication therapy
and treatment are prescribed.
(McNary, 2015) has discussed that if
we as health care providers, are able
to get to the root of the problem, to
decipher the cause of noncompliance
we can do more for patients with
mental illnesses.
In some instances,
health care providers believe that they
are not able to make a difference in
whether patients take their psychiatric
medications or not. However,
(McNary, 2015) argues that it is the
approach to the patients that helps to
make a difference by communicating
therapeutically and identifying the
patients at risk for medication
noncompliance early in the treatment
process. Evidently, there are barriers
present on both sides of the spectrum.
For the patients diagnosed with
Schizophrenia, antipsychotic
medication are usually prescribed to
help improve their symptoms but
induce negative side effects which
results in nonadherence.
Reason For Study
§ Mental illnesses affect so many 
individuals and yet, there is still 
much understanding and work to 
do to “explore how the quality of 
life, perceived stigma, and 
medication adherence differ” 
among patients with psychiatric 
disorders (Xiao-Qin Wang et al., 
2016, p. 41).
§ To evaluate medication 
adherence in patients with 
schizophrenia and possible 
interventions to alleviate the 
problem. (Yalamova, 2015) 
documents that 32.5% of  patients  
with schizophrenia would adhere 
to prescribed treatment in the 
first month, that significantly 
lessens to 16.7% within 6 months. 
Underlying Pathophysiology
A 25-year-old male was found wandering in a city park by police
officers. The man was talking to himself and became belligerent as officials
approached him. The man was unable to state his name or his address. He was
taken to the nearest emergency room where he was seen by a general
physician. The patient is observed by emergency room nurse, to be confused
and with suicidal ideation. His vital signs 180/70 blood pressure, pulse 156,
temperature 39 degrees Celsius and respirations 36. During this time, a consult
was placed to the on-call psychiatrist, the patient is being treated with Haldol
5mg and Ativan 2mg intermittently. The patient is now having both visual and
auditory hallucinations and threatening to hurt himself and staff members. An
electrocardiogram, blood samples, drug screen are ordered. Two hours later,
the patient is getting more aggressive and his vitals remain abnormal. The
result of the electrocardiogram is sinus tachycardia, the laboratory results were
normal and his drug screen positive for benzodiazepines and cocaine. The
psychiatrist sees the patient after four hours. The now restrained patient is
diagnosed with schizophrenia with acute psychosis related to noncompliance of
psychiatric medication therapy and illicit drug use.
After day three of admitted to a medical surgical unit, the
patient received supportive care. The psychiatrist reordered his psychiatric
medications he was taking at home, the patient is calmer now and coherent.
The patient states he was not able to afford his psychiatric medications and he
was having terrible side effects, so he stopped taking the medicine. The nurse
educated the patient on illicit drug use and its interference with psychiatric
medication therapy and the outcomes. The patient was given a compassionate
care package of free medications provided by the hospitals outreach program.
The next day, the patient opted to go to a psychiatric facility to access the
resources he needs to help him with his mental health disorder and better
manage his lifestyle.
Copyright: Anatomy of an Epidemic, 2010
The following outlines the ways in which patients with Schizophrenia become
nonadherent to psychiatric medication therapy, the barriers present and
results:
§ Lack of insight: This will result in nonadherence. It is important for
patients with schizophrenia to understand not only why they are
taking antipsychotic medications but also the basic function of the
brain. For example; the abnormalities linked with neurotransmitters,
the increase of dopamine levels induced schizophrenic symptoms
(Howes et al., 2015).
§ Side effects: This is one of the most prevalent reasons for
noncompliance. The patients diagnosed with schizophrenia, usually
in their twenties has reached the prime of their lives. The use of
newly prescribed antipsychotics can cause mood instability, lack of
sexual functionality or drive, fatigue which at that age interrupts the
quality of life for these individuals which may add to relapse
(Endriyani et al., 2017).
§ Lack of support: most patients with schizophrenia will need a
support system to help guide their care. Including family members
are and effective way to promote medication adherence and
improve quality of life (Caqueo-Urizar et al., 2017).
§ Socio-economic status: Some patients lack the financial resources to
pay for their medications. Implementation of an assistance program
within the hospital setting or clinics can help reduce risk for patients
with schizophrenia relapsing and experiencing adverse reactions
from psychiatric medication withdrawal (Randall et al., 2017).




• Psychosis from nonadherence to
psychiatric medication (Randall et al.,
2017). The development of alterations in
perception that affects hearing and
vision (National Institute of Mental
Health, 2020).
• Negative Symptoms that include fatigue,
lack of interest (depression), social
withdrawal and flat affect (National
Institute of Mental Health, 2020).
• Cognitive impairment such as difficulty
concentrating, staying focused and
recalling important information
(National Institute of Mental Health,
2020).
The use of therapeutic communication and appropriate
nursing education may help provide better outcomes for
patients with schizophrenia. Open communication allows
patients to express themselves and realize that they can
become empowered with knowledge of how to manage
their disorder (Virgolesi et al., 2017).
According to (McNary, 2015) she advises health care
providers to communicate effectively with patients that are
noncompliant with psychiatric medications, provide referrals
and resources, follow up after discharge from hospital.
Some patients may have difficulty with vision or cognitivr
impairments; find out how they are taking their medications
and when, include proper labeling that makes it easier for
them to see what they are taking (McNary, 2015).
Patients with diagnosed with schizophrenia are at risk for
noncompliance or Nonadherence to psychiatric medication therapy.
The earlier this attitude is identified; the sooner health care providers
can help reintegrate them with appropriate treatment modalities.
Health care providers share only half of the burden relating to
medication adherence in patients with mental health disorders. It’s
understood that the is responsible for themselves and complying with
treatment. Human behavior creates a boundary to how much health
care providers can do for patients. However, there are ways in which
health care providers can follow through and increase medication
adherence, promoting healthier outcomes and diametrically
influencing the quality of life of the schizophrenic patient in a positive
way (McNary, 2015).
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